Phosphoinositide 3-kinase modulation of β3-integrin represents an endogenous "braking" mechanism during neutrophil transmatrix migration
Phosphoinositide 3-kinase modulation of β3-integrin represents an endogenous "braking" mechanism during neutrophil transmatrix migration
复制标题
DOI:
10.1182/blood.v97.10.3251
复制
发表时间:
2001-05-15
期刊:
影响因子:
20.3
通讯作者:
Colgan, SP
中科院分区:
文献类型:
--
作者:
Bruyninckx, WJ;Comerford, KM;Colgan, SP
During episodes of inflammation, neutrophils (polymorphonuclear leukocytes [PMNs]) encounter subendothelial matrix substrates that may require additional signaling pathways as directives for movement through the extracellular space. Using an in vitro endothelial and epithelial model, inhibitors of phosphoinositide 3-kinase (PI3K) were observed to promote chemoattractant-stimulated migration by as much as 8 +/- 0.3-fold. Subsequent studies indicated that PMNs respond in a similar manner to RGD-containing matrix substrates and that PMN-matrix interactions are potently inhibited by antibodies directed against beta (3)- but not beta (1)-integrin antibodies, and that PI3K inhibitors block beta (3)-integrin dependence. Biochemical analysis of intracellular beta (3)-integrin uncoupling by PI3K inhibitors revealed diminished beta (3)-integrin tyrosine phosphorylation and decreased association with p72(syk). Similarly, the p72(syk) inhibitor piceatannol promoted PMN transmatrix migration, whereas HIV-tat peptide-facilitated loading of peptides corresponding to the beta (3)-integrin cytoplasmic tall identified the functional tyrosine residues for this activity. These data indicate that PI3K-regulated beta (3)-integrin represents a natural "braking" mechanism for PMNs during transit through the extracellular matrix. (Blood. 2001;97:3261-3258) (C) 2001 by The American Society of Hematology.